Advances in Precision Medicine for Gynecologic Cancers: Clinical Application for Nursing Practice

Learning Objectives:,Upon completion of this activity, participants should be able to:,• Discuss with patients the available data surrounding the rationale for targeting predictive biomarkers in gynecologic malignancies,• Counsel patients on the administration and potential toxicities of immune checkpoint inhibitors and PARP inhibitors as single-agent or combination therapies for the treatment of cervical, endometrial, and ovarian cancer,• Describe available maintenance therapies for patients with ovarian cancer with or without BRCA mutations or other homologous recombination repair deficiencies in the frontline and relapsed settings,• Recognize and manage irAEs in patients receiving immune checkpoint inhibitor therapy,• Develop a proactive management plan to support adherence in patients receiving oral PARP inhibitor therapy,Additional details will be posted as soon as information is available.